Skip to main content
TOPICS
Videos
Podcasts
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Lila Biologics
Lila Biologics, Eli Lilly partner for radioligand therapies
By
Anthony Vecchione
|
12:24 pm |
September 05, 2025
The alliance will center on the discovery, development and commercialization of radioligand therapies for imaging and treatment of solid tumors.
